Measurement and determinants of tuberculosis outcome in Karonga District, Malawi (Q36551873)

14 August 2017

Measurement and determinants of tuberculosis outcome in Karonga District, Malawi (English)

1 reference

14 August 2017

0 references

0 references

J R Glynn

1

1 reference

14 August 2017

D K Warndorff

2

1 reference

14 August 2017

P E Fine

3

1 reference

14 August 2017

M M Munthali

4

1 reference

14 August 2017

W Sichone

5

1 reference

14 August 2017

J M Pönnighaus

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

14 August 2017

11

1 reference

Bulletin of the World Health Organization

inferred from page(s)

published in

1 reference

14 August 2017

76

1 reference

14 August 2017

3

1 reference

14 August 2017

295-305

1 reference

Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

The distribution and implications of BCG scars in northern Malawi

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

The global tuberculosis situation and the new control strategy of the World Health Organization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

The point of view of a high prevalence country: Malawi

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2305706

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9744250

12 December 2020

inferred from PubMed ID database lookup

The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9744250

12 December 2020

inferred from PubMed ID database lookup

Sputum smear conversion during directly observed treatment for tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9744250

12 December 2020

inferred from PubMed ID database lookup

Identifiers

1 reference

14 August 2017

1 reference